Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 24, 2016

Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis

Peter Schuff-Werner EMAIL logo , Peter Kohlschein , Aliaksandra Maroz , Joachim Linssen , Katrin Dreißiger and Christine Burstein

Abstract

Background:

The distinction between reactive and neoplastic leukocytes, especially atypical lymphocytes suspected to be reactive or neoplastic, is a particular challenge in automated hematological cell differentiation. The aim of the study was to evaluate the performance of the XN analyzer supplemented with the WPC channel for differentiating between reactive and neoplastic leukocytosis.

Methods:

Blood samples of 253 patients with viral infections, lymphoma or leukemia were analyzed by the Sysmex XN-2000 analyzer equipped with the WPC channel. The results were compared to routine leukocyte differentiation using the routine Sysmex XE-2100 analyzer and automated digital microscopy (DM96). The combined information from standard morphology, immune phenotyping and clinical diagnosis served as a reference.

Results:

The XN WPC channel demonstrated an excellent performance for differentiating neoplastic (AUC=0.933) and reactive leukocytosis (AUC=0.900) as compared to morphological smear examination (AUC=0.949 and AUC=0.968, respectively) or to the differentiation results of our routine hematology analyzer (AUC=0.630 and AUC=0.635, respectively).

Conclusions:

Our data show that the combined WDF/WPC of the Sysmex XN-Series analyzer is advantageous in the automated differentiation of neoplastic and reactive leukocytosis, thus supporting the correct diagnostic decision in the daily laboratory routine.


Corresponding author: Peter Schuff-Werner, Rostock University Medical Center, Institute of Clinical Chemistry and Laboratory Medicine, Ernst-Heydemann-Str. 8, 18057 Rostock, Germany, E-mail: ;

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. PSW and PK contributed equally to this paper.

  2. Research funding: The study was supported by a grant from Sysmex Europe, Norderstedt, to cover the cost of reagents. Travel costs declared by PSW for participation at scientific meetings were covered in part by Sysmex Europe.

  3. Employment or leadership: AM and JL are full time employees of Sysmex Europe.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Simon MW. The atypical lymphocyte. Int Pediatr 2003;18:20–2.Search in Google Scholar

2. Baurmann H, Bettelheim P, Diem H, Gassmann W, Nebe T. Lymphocyte morphology in the peripheral blood film: proposal of a revised nomenclature and systematics. Lab Med 2011;35:261–70.10.1515/JLM.2011.037etSearch in Google Scholar

3. Zini G, Bain B, Bettelheim P, Cortez J, d’Onofrio G, Faber E, et al. A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty. Br J Haematol 2010;151:359–64.10.1111/j.1365-2141.2010.08366.xSearch in Google Scholar PubMed

4. George TI. Malignant or benign leukocytosis. In: Hematology Education: the education program for annual congress of the European Hematology Association, The Hague, Netherlands: European Hematology Association. 2012;2:475–84.10.1182/asheducation.V2012.1.475.3798515Search in Google Scholar

5. van der Meer W, Scott CS, de Keijzer MH. Automated flagging influences the inconsistency and bias of band cell and atypical lymphocyte morphological differentials. Clin Chem Lab Med 2004;42:371–7.Search in Google Scholar

6. Barnes PW, McFadden SL, Machin SJ, Simson E. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol 2005;11:83–90.10.1532/LH96.05019Search in Google Scholar PubMed

7. Briggs C, Longair I, Kumar P, Singh D, Machin SJ. Performance evaluation of the Sysmex haematology XN modular system. J Clin Pathol 2012;65:1024–30.10.1136/jclinpath-2012-200930Search in Google Scholar PubMed

8. Jones AS, Tailor H, Liesner R, Machin SJ, Briggs CJ. The value of the white precursor cell channel (WPC) on the Sysmex XN-1000 analyser in a specialist paediatric hospital. J Clin Pathol 2015;68:161–5.10.1136/jclinpath-2014-202640Search in Google Scholar PubMed

9. Bruegel M, Nagel D, Funk M, Fuhrmann P, Zander J, Teupser D. Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-2100, and Sysmex XN-2000. Clin Chem Lab Med 2015;53:1057–71.10.1515/cclm-2014-0945Search in Google Scholar PubMed

10. Seo J, Lee S, Kim S. Performance evaluation of the new hematology analyzer Sysmex XN-series. Int J Lab Hematol 2015;37:155–64.10.1111/ijlh.12254Search in Google Scholar PubMed

11. World Health Organization. International classification of diseases and delated health problems, 10th edition. 2010 [cited 2014]. Available from: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf.Search in Google Scholar

12. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, editors. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed. IARC: Lyon, 2008:439.Search in Google Scholar

13. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 2001;125:391–6.10.5858/2001-125-0391-TNHASXSearch in Google Scholar PubMed

14. Takagi Y, Kono M, Yamamoto S, Wada A, Morikawa T. Comparison of optical data from flow cytometry and microscopy of leukocytes after exposure to specific reagents. Microscopy (Oxf) 2015;64:305–10.10.1093/jmicro/dfv023Search in Google Scholar PubMed

15. Gottfried EL. Lipids of human leukocytes: relation to celltype. J Lipid Res 1967;8:321–7.10.1016/S0022-2275(20)39561-4Search in Google Scholar

16. Kuliszkiewicz-Janus M, Tuz MA, Kielbinski M, Jazwiec B, Niedoba J, Baczynski S. 31P MRS analysis of the phospholipid composition of the peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) of patients with acute leukemia (AL). Cell Mol Biol Lett 2009;14:35–45.10.2478/s11658-008-0032-7Search in Google Scholar PubMed PubMed Central

17. El Kirat K, Morandat S. Cholesterol modulation of membrane resistance to Triton X-100 explored by atomic force microscopy. Biochim Biophys Acta 2007;1768:2300–9.10.1016/j.bbamem.2007.05.006Search in Google Scholar PubMed

18. Kawauchi S, Kono M, Takagi Y, Wada A, Morikawa T. The positions of normal leukocytes on the scattergram of the newly developed abnormal cell-detection channel of the XN-Series multi-parameter automated hematology analyzers. Sysmex J Int 2013;23:1–9.Search in Google Scholar

Received: 2015-11-12
Accepted: 2016-1-6
Published Online: 2016-2-24
Published in Print: 2016-9-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.11.2022 from frontend.live.degruyter.dgbricks.com/document/doi/10.1515/cclm-2015-1105/html
Scroll Up Arrow